Aaron Cowen - Net Worth and Insider Trading

Aaron Cowen Net Worth

The estimated net worth of Aaron Cowen is at least $11 Million dollars as of 2024-12-28. Aaron Cowen is the 10% Owner of ProKidney Corp and owns about 6,280,175 shares of ProKidney Corp (PROK) stock worth over $11 Million. Details can be seen in Aaron Cowen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aaron Cowen has not made any transactions after 2022-09-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Aaron Cowen

Aaron Cowen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Aaron Cowen owns 6 companies in total, including Social Capital Suvretta Holdings Corp I (DNAA) , Social Capital Suvretta Holdings Corp III (DNAC) , and Social Capital Suvretta Holdings Corp II (DNAB) among others .

Click here to see the complete history of Aaron Cowen’s form 4 insider trades.

Insider Ownership Summary of Aaron Cowen

Ticker	Comapny	Transaction Date	Type of Owner
DNAA	Social Capital Suvretta Holdings Corp I	2021-06-29	other: Manager of Minority Owner
DNAC	Social Capital Suvretta Holdings Corp III	2021-06-29	other: Manager of Minority Owner
DNAB	Social Capital Suvretta Holdings Corp II	2021-06-29	other: Manager of Minority Owner
		2021-06-29	other: Manager of Minority Owner
		2021-06-29	other: Manager of Minority Owner
		2023-03-31	10 percent owner

Aaron Cowen Latest Holdings Summary

Aaron Cowen currently owns a total of 1 stock. Aaron Cowen owns 6,280,175 shares of ProKidney Corp (PROK) as of September 6, 2022, with a value of $11 Million.

Latest Holdings of Aaron Cowen

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PROK	ProKidney Corp	2022-09-06	6,280,175	1.70	10,676,298

Holding Weightings of Aaron Cowen

Aaron Cowen Form 4 Trading Tracker

According to the SEC Form 4 filings, Aaron Cowen has made a total of 2 transactions in ProKidney Corp (PROK) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in ProKidney Corp is the acquisition of 7,007 shares on September 6, 2022, which cost Aaron Cowen around $48,979.

Insider Trading History of Aaron Cowen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Aaron Cowen Trading Performance

GuruFocus tracks the stock performance after each of Aaron Cowen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aaron Cowen is 28.32%. GuruFocus also compares Aaron Cowen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aaron Cowen within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Aaron Cowen's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Aaron Cowen

Average Return

Average return per transaction

Outperforming Transactions

1 out of 2 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	17.28
Relative Return to S&P 500(%)	24.05

Aaron Cowen Ownership Network

Ownership Network List of Aaron Cowen

No Data

Ownership Network Relation of Aaron Cowen

Aaron Cowen Owned Company Details

What does Social Capital Suvretta Holdings Corp I do?

Who are the key executives at Social Capital Suvretta Holdings Corp I?

Aaron Cowen is the other: Manager of Minority Owner of Social Capital Suvretta Holdings Corp I. Other key executives at Social Capital Suvretta Holdings Corp I include Chief Financial Officer James Ryans , other: Manager Chamath Palihapitiya , and other: Manager Kishan Mehta .

Social Capital Suvretta Holdings Corp I (DNAA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Social Capital Suvretta Holdings Corp I (DNAA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Social Capital Suvretta Holdings Corp I (DNAA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Social Capital Suvretta Holdings Corp I (DNAA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Social Capital Suvretta Holdings Corp I Insider Transactions

No Available Data

What does Social Capital Suvretta Holdings Corp III do?

Who are the key executives at Social Capital Suvretta Holdings Corp III?

Aaron Cowen is the other: Manager of Minority Owner of Social Capital Suvretta Holdings Corp III. Other key executives at Social Capital Suvretta Holdings Corp III include 10 percent owner Control Empresarial De Capitales S.a. De C.v. , 10 percent owner Sc Pipe Holdings Llc , and 10 percent owner Tolerantia, Llc .

Social Capital Suvretta Holdings Corp III (DNAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Social Capital Suvretta Holdings Corp III (DNAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Social Capital Suvretta Holdings Corp III (DNAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Social Capital Suvretta Holdings Corp III (DNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Social Capital Suvretta Holdings Corp III Insider Transactions

No Available Data

What does Social Capital Suvretta Holdings Corp II do?

Who are the key executives at Social Capital Suvretta Holdings Corp II?

Aaron Cowen is the other: Manager of Minority Owner of Social Capital Suvretta Holdings Corp II. Other key executives at Social Capital Suvretta Holdings Corp II include Chief Financial Officer James Ryans , other: Manager Chamath Palihapitiya , and other: Manager Kishan Mehta .

Social Capital Suvretta Holdings Corp II (DNAB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Social Capital Suvretta Holdings Corp II (DNAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Social Capital Suvretta Holdings Corp II (DNAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Social Capital Suvretta Holdings Corp II (DNAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Social Capital Suvretta Holdings Corp II Insider Transactions

No Available Data

What does Social Capital Suvretta Holdings Corp IV do?

Who are the key executives at Social Capital Suvretta Holdings Corp IV?

Aaron Cowen is the other: Manager of Minority Owner of Social Capital Suvretta Holdings Corp IV. Other key executives at Social Capital Suvretta Holdings Corp IV include Chief Financial Officer James Ryans , other: Manager Chamath Palihapitiya , and other: Manager Kishan Mehta .

Social Capital Suvretta Holdings Corp IV (DNAD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Social Capital Suvretta Holdings Corp IV (DNAD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Social Capital Suvretta Holdings Corp IV (DNAD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Social Capital Suvretta Holdings Corp IV (DNAD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Social Capital Suvretta Holdings Corp IV Insider Transactions

No Available Data

What does Akili Inc do?

Who are the key executives at Akili Inc?

Aaron Cowen is the other: Manager of Minority Owner of Akili Inc. Other key executives at Akili Inc include Chief Legal Officer Jacqueline Studer , See Remarks Matthew Franklin , and director & Chief Executive Officer Martucci Walter Edward Ii .

Akili Inc (AKLI) Insider Trades Summary

Over the past 18 months, Aaron Cowen made no insider transaction in Akili Inc (AKLI). Other recent insider transactions involving Akili Inc (AKLI) include a net sale of 2,353 shares made by Martucci Walter Edward Ii , a net sale of 1,728 shares made by Matthew Franklin , and a net sale of 1,130 shares made by Jacqueline Studer .

In summary, during the past 3 months, insiders sold 0 shares of Akili Inc (AKLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,041 shares of Akili Inc (AKLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,041 shares.

Akili Inc (AKLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Akili Inc Insider Transactions

No Available Data

What does ProKidney Corp do?

Who are the key executives at ProKidney Corp?

Aaron Cowen is the 10 percent owner of ProKidney Corp. Other key executives at ProKidney Corp include SVP of Regulatory Development Darin J. Weber , director & 10 percent owner Pablo G. Legorreta , and 10 percent owner Control Empresarial De Capitales S.a. De C.v. .

ProKidney Corp (PROK) Insider Trades Summary

Over the past 18 months, Aaron Cowen made no insider transaction in ProKidney Corp (PROK). Other recent insider transactions involving ProKidney Corp (PROK) include a net sale of 13,273,000 shares made by Chamath Palihapitiya , a net sale of 170,593 shares made by Darin J. Weber , and a net purchase of 8,441,462 shares made by Control Empresarial De Capitales S.a. De C.v. .

In summary, during the past 3 months, insiders sold 0 shares of ProKidney Corp (PROK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 13,443,593 shares of ProKidney Corp (PROK) were sold and 31,059,371 shares were bought by its insiders, resulting in a net purchase of 17,615,778 shares.

ProKidney Corp (PROK)'s detailed insider trading history can be found in Insider Trading Tracker table.

ProKidney Corp Insider Transactions

No Available Data

Aaron Cowen Mailing Address

Above is the net worth, insider trading, and ownership report for Aaron Cowen. You might contact Aaron Cowen via mailing address: 540 Madison Avenue, 7th Floor, New York Ny 10022.

Discussions on Aaron Cowen

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.